Navigation Links
CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment
Date:5/31/2011

uent dosing.

Preclinical studies have confirmed that CSL Behring's rVIIa-FP has favorable pharmacokinetic properties compared to the existing recombinant product. A half-life extension of greater than 8-fold has been observed. The use of a bypassing agent with an extended half-life could offer significant benefit to those affected by hemophilia A or B with inhibitors and may offer patients the opportunity to be treated less frequently than with the currently available product.

CSL Behring's clinical program intends to demonstrate that an extended half-life rVIIa-FP will result in a requirement for fewer doses while providing adequate therapeutic response in patients with hemophilia A and B with inhibitors.

About CSL Behring

CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide. CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in newborns. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. CSL Behring is a subsidiary of CSL Limited (ASX: CSL), a biopharmaceutical company headquartered in Melbourne, Australia. For more information, visit www.cslbehring.com.

Contact:
Sheila A. Burke, Director, Communications & Public Relations
Worldwide Commercial Operations
CSL Behring
C: 484-919-2618
O: 610-878-4209

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. National Organization for Rare Disorders Presents CSL Behring With 2011 Corporate Award
2. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
3. CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti
4. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
5. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
6. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
7. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
8. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
9. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
10. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
11. Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Calif. , May 5, 2015  Desert Valley Medical ... times , is the first U.S. hospital to deploy ... Delivery rooms to help reduce the duration of labor and ... is shortened and the risk of caesarean birth is reduced ... However, most mothers in labor are given epidurals and ...
(Date:5/5/2015)...  IQPC,s 19 th Software Design for Medical ... the Summit Mr. Phani Bidarahalli , GM & Head ... the expert speaker faculty including senior executive from GE Healthcare, ... at The Hotel Kabuki in San Francisco ... on the event website, which can be accessed by visiting ...
(Date:5/5/2015)... -- Big Market Research presents a detailed analysis of ... , ( France , Germany , ... and Japan . Current scientific views on the ... 5-year test volume and sales forecasts by country for HAV NAT, ... Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the ...
Breaking Medicine Technology:Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3
... DIEGO, Jan. 10, 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: ... Linda Amper, Ph.D., as Senior Vice President of Human ... Economics & Outcomes Research (HEOR), and John Womelsdorf, Ph.D., ... will strengthen the management team as the Company prepares ...
... Calif., Jan. 10, 2011 OncoMed Pharmaceuticals, Inc., ... today announced that patient dosing has commenced in a Phase ... tumor cancers.   OMP-59R5 is a monoclonal antibody ... to specifically block these targets to enter human studies.  The ...
Cached Medicine Technology:Optimer Pharmaceuticals Announces Key Additions to Management Team 2Optimer Pharmaceuticals Announces Key Additions to Management Team 3Optimer Pharmaceuticals Announces Key Additions to Management Team 4OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 2OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 3
(Date:5/5/2015)... May 05, 2015 Horizon Blue Cross ... strong and secure credit rating of “A” from Standard ... financials last week, the Wall Street ratings agency cited ... market position” in determining the rating and “stable” outlook. ... one of our top priorities, so we are pleased ...
(Date:5/5/2015)... York, New York (PRWEB) May 05, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) filed on behalf ... complications due to their use of prescription ... in the federal multidistrict litigation underway in ... According to court documents dated May 1st, ...
(Date:5/5/2015)... 05, 2015 Sunny skies and cool temperatures ... as nearly 400 runners and walkers participated in Global Lyme ... nearly $35,000. , The 5K and 10K runs and ... disease and to raise funds for tick-borne disease research. The ... the recent merger of Lyme Research Alliance (LRA) ...
(Date:5/5/2015)... Creek, Michigan (PRWEB) May 05, 2015 In ... media outlet The Herald-Times , the Missouri State Highway ... involving Crystal Methamphetamine production or use for the second year ... meth statistics to the FBI, reported 1,469 incidents in 2014 ... into perspective, only around 2% of the US Population calls ...
(Date:5/5/2015)... The brains of people with type 1 ... slower information processing, according to research led by the ... . , The findings indicate that clinicians should ... cognitive difficulties. If progressive, these changes could influence their ... the National Institutes of Health (NIH), is ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4
... ... plastic surgery celebrates its 10 year Anniversary. , ... (PRWEB) June 20, 2010 -- Having grown from a small internet startup ... proud to mark its 10th anniversary this summer by thanking all the clients, customers, and ...
... ... company, has announced that it will launch a host of exciting new products at V-Malaysia ... , ... QuestNet , an international direct selling and network marketing company, has announced that it ...
... ... 88-year-old woman from Brooklyn, NY, lost her life savings of $60,000 by ... was a winner when she started receiving solicitations with phrasing like “You ... claim your check” printed in large colorful fonts, along with official looking ...
... games main reasons for spike between 2008 and 2009, ... Summer activity-related head injuries appear to be on the ... and bicycling, water sports and baseball/softball are the main ... of head injury trends as they transpired between 2008 ...
... of deaths in a study of 12,000 Bangladeshis were attributable ... The large 10-year study is the first to ... its associated mortality risk, the authors said. The data, collected ... will be published early online Saturday in The Lancet ...
... terms of increased libido, studies found , FRIDAY, June 18 ... panel on Friday unanimously agreed that a pill dubbed by ... benefits to warrant approval. , Called flibanserin, the drug was ... is related to the antidepressant family and affects serotonin and ...
Cached Medicine News:Health News:Signature Forum Celebrates 10th Anniversary 2Health News:QuestNet to Launch New Consumable Products at Annual Convention 2Health News:QuestNet to Launch New Consumable Products at Annual Convention 3Health News:QuestNet to Launch New Consumable Products at Annual Convention 4Health News:Senior Citizen Defrauded By Sweepstakes Scams Wins Big With The National Telemarketing Victim Call Center And Recovers $14,000.00 2Health News:Senior Citizen Defrauded By Sweepstakes Scams Wins Big With The National Telemarketing Victim Call Center And Recovers $14,000.00 3Health News:Senior Citizen Defrauded By Sweepstakes Scams Wins Big With The National Telemarketing Victim Call Center And Recovers $14,000.00 4Health News:Bump in Head Injury Numbers Linked to Summer Play 2Health News:Deadly effect of arsenic in drinking water measured in massive study 2Health News:Deadly effect of arsenic in drinking water measured in massive study 3
Full plate covers seal all 24 MicroAmp tubes...
An alternative sealing method for samples that are stored in 96-well plates after PCR. The mat is fully autoclavable and can be reused up to 50 times....
Inquire...
Pkg qty: box of 2 bags pack of 25 (Pack = Zippered Bag)...
Medicine Products: